Cite
Sultan A, Hanna GJ, Margalit DN, et al. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017;22(11):1413doi: 10.1634/theoncologist.2016-0298erratum.
Sultan, A., Hanna, G. J., Margalit, D. N., Chau, N., Goguen, L. A., Marty, F. M., Rabinowits, G., Schoenfeld, J. D., Sonis, S. T., Thomas, T., Tishler, R. B., Treister, N. S., Villa, A., Woo, S. B., Haddad, R., & Mawardi, H. (2017). The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. The oncologist, 22(11), 1413. https://doi.org/10.1634/theoncologist.2016-0298erratum
Sultan, Ahmed, et al. "The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline." The oncologist vol. 22,11 (2017): 1413. doi: https://doi.org/10.1634/theoncologist.2016-0298erratum
Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 Nov;22(11):1413. doi: 10.1634/theoncologist.2016-0298erratum. PMID: 29123016; PMCID: PMC5679836.
Copy
Download .nbib